The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review.
OBJECTIVES: Myasthenia gravis (MG) is an immune-mediated disorder associated with autoantibodies against postsynaptic nicotinic acetylcholine receptors at neuromuscular junctions.Rituximab, a monoclonal antibody specific for CD20, is used primarily to treat B-cellnon-Hodgkin lymphoma.Although it has been used for treatment of a number of autoimmune diseases, there is limited experience in MG.METHODS: Three patients with refractory MG (2 with concurrent thymoma) were given rituximab.RESULTS: Symptoms stabilized and reductions in immunosuppressive medications were tolerated for extended periods, without adverse effects or infectious complications.CONCLUSIONS: These observations support the concept that rituximab may be helpful for the treatment of MG.Remissions in patients with or without thymoma are achievable with rituximab given in combination with commonly used modalities.Furthermore, rituximab is not necessarily contraindicated for the treatment of MG in patients being treated for thymoma.Controlled studies are called for to define its role in the treatment of refractory MG.[1]
